Voyager Therapeutics VYGR
NASDAQ VYGR
$2.45 -0.22 (-8.41%)
At close: Oct 2, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Selling, General & Administrative (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded Selling, General & Administrative of $7.52 million in Q2 2026, down 28.4% from $10.5 million a year earlier and down 9.0% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Selling, General & Administrative (2014 - 2026) Analysis & Trends

On a TTM basis, Voyager Therapeutics' Selling, General & Administrative came in at $33.19 million as of Jun 30, 2026, down 11.0% year-over-year; for FY2025, it was $37.54 million, up 4.5% from FY2024.

  • Annual Selling, General & Administrative has increased for three straight years, with a five-year compound annual growth rate of 1.4% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $35.92 million in FY2024 (+0.3%), $35.82 million in FY2023 (+15.6%), $30.98 million in FY2022 (-16.8%) and $37.25 million in FY2021 (+6.4%).
  • The Q2 2026 figure is the lowest quarterly Selling, General & Administrative since Q3 2022.
  • On a year-over-year basis, Selling, General & Administrative rose in three of the last eight quarters, with an average decline of 4.7%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 22.4% in Q2 2024, against a decline of 28.4% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8.26 million (Q1 2026), $9.32 million (Q4 2025) and $8.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Voyager Therapeutics 163.60 Mn -499.59 Mn - 7.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.52 Mn
Mar 31, 2026 8.26 Mn
Dec 31, 2025 9.32 Mn
Sep 30, 2025 8.09 Mn
Jun 30, 2025 10.50 Mn
Mar 31, 2025 9.64 Mn
Dec 31, 2024 8.99 Mn
Sep 30, 2024 8.17 Mn
Jun 30, 2024 10.15 Mn
Mar 31, 2024 8.61 Mn
Dec 31, 2023 10.24 Mn
Sep 30, 2023 8.26 Mn
Jun 30, 2023 8.29 Mn
Mar 31, 2023 9.03 Mn
Dec 31, 2022 8.46 Mn
Sep 30, 2022 7.31 Mn
Jun 30, 2022 7.55 Mn
Mar 31, 2022 7.66 Mn
Dec 31, 2021 8.35 Mn
Sep 30, 2021 8.71 Mn
API Access

Voyager Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VYGR&period=max&api_key=YOUR_API_KEY